发明名称 |
P97-antibody conjugates and methods of use |
摘要 |
The present invention provides p97-antibody conjugates and related compositions and methods, which may be used in any of a variety of therapeutic methods, including methods for the treatment of cancers such as Her2/neu-expressing and Her1/EGFR-expressing cancers. |
申请公布号 |
US9150846(B2) |
申请公布日期 |
2015.10.06 |
申请号 |
US201213542435 |
申请日期 |
2012.07.05 |
申请人 |
biOasis Technologies, Inc. |
发明人 |
Jefferies Wilfred;Vitalis Timothy Z.;Gabathuler Reinhard |
分类号 |
A61K47/48;C07K14/79;C12N9/96;C07K16/32;C12N9/14;A61K45/06 |
主分类号 |
A61K47/48 |
代理机构 |
Cooley LLP |
代理人 |
Cooley LLP |
主权项 |
1. A conjugate comprising a p97 polypeptide covalently or operatively linked to an antibody or antigen-binding fragment thereof that specifically binds the human Her2/neu protein, wherein the p97 polypeptide is a soluble p97 polypeptide that has a deletion of all or a portion of the hydrophobic domain as defined by residues 710-738 of SEQ ID NO: 1, and where the p97 polypeptide is effective for transporting the anti-Her2/neu antibody across the blood brain barrier. |
地址 |
Richmond CA |